Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Complement System01:27

Complement System

2.4K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.4K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

8.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.3K
Coagulation01:09

Coagulation

7.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

749
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
749
Introduction to Hemostasis01:05

Introduction to Hemostasis

8.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.3K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

6.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Targets for disease modification in schizophrenia: New findings add to evidence for the involvement of the immune complement system.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Fitusiran treatment modulates the ratio between alpha- and beta-antithrombin isoforms.

HemaSphere·2026
Same author

<i>Erratum</i> to: "Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic mice".

Haematologica·2025
Same author

A bispecific nanobody for the treatment of von Willebrand disease type 1.

Blood·2025
Same author

Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic mice.

Haematologica·2025
Same author

Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptides.

Haematologica·2025

相关实验视频

Updated: Jul 18, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.0K

补充和凝结交叉声 - 聚焦的H因子

Meike Heurich1, Geneviève McCluskey2

  • 1School of Pharmacy and Pharmaceutical Sciences, College of Biomedical and Life Sciences, Cardiff University, United Kingdom.

Immunobiology
|August 26, 2023
PubMed
概括

免疫补充和凝血系统相互作用,H因子影响两者. 这种交叉影响它们的激活,调节和疾病中的潜在作用,突出了H因子.

科学领域:

  • 基于血液的蛋白质溶解级联.
  • 免疫学和血液学 免疫学和血液学
  • 分子相互作用分子相互作用.

背景情况:

  • 补充和凝固系统是不同的,但同源的蛋白质溶解级联.
  • 微妙的平衡和监管对这两个系统都至关重要.
  • 报道了补充剂和凝血之间的相互作用,影响了它们的功能.

研究的目的:

  • 审查关于凝血因子在补充替代途径激活和调节方面的文献.
  • 要突出H因子和凝固因子之间的分子相互作用.
  • 提出H因子在血液静止环境中的两个系统中的作用机制.

主要方法:

  • 科学出版物的文献评论. 科学出版物的文献评论.
  • 分析补充和凝固因子之间的分子相互作用.
  • 综合了有关H因子作用的现有数据.

主要成果:

  • 凝血因子有助于补充替代途径的激活和调节.
  • H因子与几个凝血因子相互作用.
  • H因子可以调节补充和凝血激活和调节.

结论:

关键词:
凝血是凝固的过程.补充 补充 补充 补充交叉窃听是一种交叉窃听.这就是H因子.

更多相关视频

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

8.4K
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

6.0K

相关实验视频

Last Updated: Jul 18, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.0K
Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

8.4K
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

6.0K
  • H因子在调节凝血方面发挥作用.
  • 在静血系统内,H因子和凝血因子之间的相互作用是显著的.
  • H因子的调节失调或凝血可能会影响涉及这些途径的疾病.